Journals / Nöropsikiyatri Arşivi / 2016 / Cilt: 53 - Sayı: 1

Büyük Oksipital Sinir Blokajının Migren Profilaksisindeki Etkinliği

Effectiveness of Greater Occipital Nerve Blocks in Migraine Prophylaxis

Pages
45–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Consequently, these results show that repeated GON blocks with local anesthetic can be an effective alternative treatment in migraine patients who are unresponsive to medical prophylaxis or who do not prefer to use medical prophylaxis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Peripheral nerve blocks have been used in primary headache treatment since a long time.
📊
Key Findings & Data:Methods: Data from migraine without aura patients who had GON block were collected and divided into two groups: Group PGON (n=25), which included patients who were under medical prophylaxis and had GON block, and Group GON (n=53), which included patients who had only GON blocks.
💡
Conclusion & Impact:Consequently, these results show that repeated GON blocks with local anesthetic can be an effective alternative treatment in migraine patients who are unresponsive to medical prophylaxis or who do not prefer to use medical prophylaxis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Peripheral nerve blocks have been used in primary headache treatment since a long time. In this study, we aimed to examine the efficiency of greater occipital nerve (GON) block in migraine prophylaxis. Methods: Data from migraine without aura patients who had GON block were collected and divided into two groups: Group PGON (n=25), which included patients who were under medical prophylaxis and had GON block, and Group GON (n=53), which included patients who had only GON blocks. Migraine was diagnosed using International Headache Society (IHS) classification. Data of 78 patients were analyzed. Headache attack frequency, headache duration, and severity were compared between and within groups in a 3-month follow-up period.Results: The decrease in headache parameters after GON block in both groups was significantly similar. Headache attack frequency decreased from 15.73±7.21 (pretreatment) to 4.52±3.61 (3rd month) in Group GON and from 13.76±8.07 to 3.28±2.15 in Group PGON (p<0.05) Headache duration decreased from 18.51±9.43 to 8.02±5.58 at 3rd month in Group GON and from 15.20±9.16 to 7.20±4.16 in Group PGON (p<0.05). Headache severity decreased from 8.26±1.32 to 5.16±2.64 in Group GON and from 8.08±0.90 to 5.96±1.20 in Group PGON (p<0.05). There was no statistically significant difference between the groups in 3rd month after treatment (p>0.05).Conclusion: This study showed significant decreases in headache parameters in both groups. As GON blocks were performed in patients unresponsive to medical prophylaxis, a decrease in the headache parameters in Group PGON similar to that in Group GON can be attributed to GON blocks. Consequently, these results show that repeated GON blocks with local anesthetic can be an effective alternative treatment in migraine patients who are unresponsive to medical prophylaxis or who do not prefer to use medical prophylaxis

Özet

Amaç: Periferik sinir blokları uzun süredir primer başağrılarının tedavisinde kullanılmaktadır. Bu çalışmada büyük oksipital sinir (GON) blokajının migren profilaksisinde etkinliğinin gösterilmesi amaçlanmıştır Yöntem: Büyük oksipital sinir blokajı uygulanan aurasız migren tanılı has-taların verileri toplanarak iki gruba ayrıldı. Grup PGON (n=25); medikal migren profilaksisi almakta iken GON blokajı uygulanan hastalar ve Grup GON (n=53) sadece GON blokajı uygulanan hastalar. Migren tanıları IHS sınıflamasına göre konulmuştur. Toplam 78 hasta verileri analiz edil-miştir. Üç aylık takip perioduna ait verilerde başağrısı atak frekansı, ba-şağrısı süresi ve şiddet değerleri grup içi ve gruplar arası karşılaştırılmıştır.Bulgular: Büyük oksipital sinir blokajı sonrası her iki grup başağrısı ta-kip parametrelerinde benzer azalmalar göstermiştir. Grup GON de başağrısı atak frekansı 15,73±7,21'den 3. ayda 4,52±3,61'e Grup PGON'de 13,76±8,07'den 3,28±2,15'e inmiştir (p 0,05). Sonuç: Bu çalışma başağrısı parametrelerinde her iki grupta anlamlı azal-ma olduğunu göstermiştir. Grup PGON de medikal profilaksiye yeterli yanıt vermeyenlerde GON blokajı yapıldığı için Grup PGON deki başağ-rısı parametrelerinde azalma Grup GON'da olduğu gibi GON blokaj-larına bağlanmıştır. Sonuç olarak, lokal anestetiklerle yapılan tekrarlayıcı GON blokajları migren profilaksisinde özellikle medikal tedaviye yeterli yanıt vermeyen ya da kullanamayanlarda tek başına da etkili alternatif olabileceği çalışmamızda gösterilmiştir

🔖

Cite This Article

İNAN, N., İNAN, L. E., COŞKUN, Ö., TUNÇ, T., İLHAN, M. N. (2016). Büyük Oksipital Sinir Blokajının Migren Profilaksisindeki Etkinliği. Nöropsikiyatri Arşivi, Cilt: 53 - Sayı: 1, 45–48. https://ajindex.com/articles/292825

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, Onal AE, Siva A. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain 2012; 13:147-157. [CrossRef] Mathew NT, Tfelt- Hansen P. General and pharmacologic approach to mi- graine management. In: Olesen J, Goadsby PJ, Ramadan MN, Tfelt-Hansen P, Welch KMA. The Headaches Third Edition. Philadelphia. Lippincott Williams & Wilkins 2000, 433-440.
  2. Terzi T, Karakurum B, Üçler S, Inan LE, Tulunay C. Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache. J Headache Pain 2002; 3:137-141. [CrossRef] Caputi CA, Firetto V. Therapeutic blockade of the greater occipital and supra- orbital in migraine patients. Headache 1997; 37:174-179. [CrossRef] Ashkenazi A, Young WB. The effects of greater occipital nerve block and trig- ger point injection on brush allodynia and pain in migraine. Headache 2005; 45:350-354. [CrossRef] Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes- prolonged effects from a single injection. Pain 2006; 122:126-129. [CrossRef] Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cepha- lalgia 2004; 24(Suppl 1):1-160.
  3. Tobin JA, Flitman SS. Occipital nerve blocks: Effect of symptomatic medica- tion: overuse and headache type on failure rate. Headache 2009; 49:1479- 1485. [CrossRef] Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for trans- formed migraine: a randomised comparative study. J Neurol Neurosurg Psy- chiatry 2008; 79:415-417. [CrossRef] Young WB. The blocking greater occipital nerve: utility in headache manage- ment. Curr Pain Headache Rep 2010; 14:404-408. [CrossRef] Bovim G, Sand I. Cervicogenic headache, migraine without aura and ten- sion-type headache. Diagnostic blockade of the greater occipital and supraor- bital nerves. Pain 1992; 51:43-48. [CrossRef] Tobin J, Flitman S. Treatment of migraine with occipital nerve blocks using only corticosteroids. Headache 2011; 51:155-159. [CrossRef] Weibelt S, Andress-Rothrock D, King W, Rothrock J. Suboccipital nerve blocks for suppression of chronic migraine: Safety, efficacy, and predictors of out- come. Headache 2010; 50:1041-1044. [CrossRef] Young WB, Mateos V, Ashkenazi A. Occi